An ambitious new Centers for Medicare and Medicaid Innovation plan will test three new payment models aimed at lowering drug costs and increasing treatment access involving:
Medicare Will Test Payment Model For Accelerated Approvals To ‘Expedite’ Confirmatory Trials
The Center for Medicare and Medicaid Innovation also will develop demonstrations focused on payment arrangements for cell and gene therapy in Medicaid and promoting generic drugs in Medicare Part D.
